Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors
NCT04319081
·
clinicaltrials.gov ↗
COMPLETED
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Cognitive Function
Hypercholesterolemia
Quality of Life
Interventions
DRUG:
PCSK9 inhibitor
Sponsor
Jose Seijas Amigo